Estrogen receptor signaling and targets: Bones, breasts and brain (Review)

Toumba,Meropi; Kythreotis,Alexandros; Panayiotou,Konstantina; Skordis,Nicos

doi:10.3892/mmr.2024.13268

Estrogen receptor signaling and targets: Bones, breasts and brain (Review)

Authors:
- Meropi Toumba
- Alexandros Kythreotis
- Konstantina Panayiotou
- Nicos Skordis
View Affiliations

Affiliations: Department of Pediatrics, Pediatric Endocrinology Clinic, Aretaeio Hospital, Nicosia 2024, Cyprus, Barts and The London School of Medicine and Dentistry, London E1 2AD, United Kingdom, School of Medicine, University of Nicosia, Nicosia 2414, Cyprus
Published online on: June 19, 2024 https://doi.org/10.3892/mmr.2024.13268
Article Number: 144

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Estrogens are involved in a number of physiological functions, including in the development of the brain, growth, reproduction and metabolism. The biological actions of estrogens are achieved by binding to estrogen receptors (ERs) in numerous types of tissues. ERα and ERβ belong to the nuclear receptor superfamily and the G‑protein coupled ER1 (GPER1) is a membrane receptor. The primary biologically active estrogen, 17β‑estradiol demonstrates a high affinity for ERs. Mechanistically, estrogens bind to the ERs in the nucleus, and the complex then dimerize and bind to estrogen response elements (EREs) located in the promoter regions of the target genes. This is referred to as the genomic mechanism of ERs' function. Furthermore, ERs can also act through kinases and other molecular interactions leading to specific gene expression and functions, referred to as the non‑genomic mechanism. While ERα and ERβ exert their functions via both genomic and non‑genomic pathways, GPER1 exerts its function primarily via the non‑genomic pathways. Any aberrations in ER signaling can lead to one of a number of diseases such as disorders of growth and puberty, fertility and reproduction abnormalities, cancer, metabolic diseases or osteoporosis. In the present review, a focus is placed on three target tissues of estrogens, namely the bones, the breasts and the brain, as paradigms of the multiple facets of the ERs. The increasing prevalence of breast cancer, particularly hormone receptor‑positive breast cancer, is a challenge for the development of novel antihormonal therapies other than tamoxifen and aromatase inhibitors, to minimize toxicity from the long treatment regimens in patients with breast cancer. A complete understanding of the mechanism of action of ERs in bones may highlight options for novel targeted treatments for osteoporosis. Likewise, the aging of the brain and related diseases, such as dementia and depression, are associated with a lack of estrogen, particularly in women following menopause. Furthermore, gender dysphoria, a discordance between experienced gender and biological sex, is commonly hypothesized to emerge due to discrepancies in cerebral and genital sexual differentiation. The exact role of ERs in gender dysphoria requires further research.

View Figures

View References

1	Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P and Chambon P: Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature. 320:134–139. 1986. View Article : Google Scholar : PubMed/NCBI
2	Jameson L, De Groot LJ, de Kretser DM, Giudice LC, Grossman AB, Melmed S, Potts JT and Weir GC: Endocrinology: Adult and Pediatric. 7th edition. W.B Saunders; Philadelphia, PH: pp. 2200–2350. 2016
3	Fuentes N and Silveyra P: Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 116:135–170. 2019. View Article : Google Scholar : PubMed/NCBI
4	Faltas CL, LeBron KA and Holz MK: Unconventional estrogen signaling in health and disease. Endocrinology. 161:bqaa0302020. View Article : Google Scholar : PubMed/NCBI
5	Hazell GG, Yao ST, Roper JA, Prossnitz ER, O'Carroll AM and Lolait SJ: Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J Endocrinol. 202:223–236. 2009. View Article : Google Scholar : PubMed/NCBI
6	Arterburn JB and Prossnitz ER: G Protein-Coupled Estrogen Receptor GPER: Molecular pharmacology and therapeutic applications. Annu Rev Pharmacol Toxicol. 63:295–320. 2023. View Article : Google Scholar : PubMed/NCBI
7	Björnström L and Sjöberg M: Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 19:833–842. 2005. View Article : Google Scholar : PubMed/NCBI
8	Williams C, Edvardsson K, Lewandowski SA, Ström A and Gustafsson JA: A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene. 27:1019–1032. 2008. View Article : Google Scholar : PubMed/NCBI
9	Klinge CM, Jernigan SC, Smith SL, Tyulmenkov VV and Kulakosky PC: Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol Cell Endocrinol. 174:151–166. 2001. View Article : Google Scholar : PubMed/NCBI
10	Clusan L, Ferrière F, Flouriot G and Pakdel F: A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci. 24:68342023. View Article : Google Scholar : PubMed/NCBI
11	Bord S, Horner A, Beavan S and Compston J: Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab. 86:2309–2314. 2001. View Article : Google Scholar : PubMed/NCBI
12	Gosden JR, Middleton PG and Rout D: Localization of the human oestrogen receptor gene to chromosome 6q24-q27 by in situ hybridization. Cytogenet Cell Genet. 43:218–220. 1986. View Article : Google Scholar : PubMed/NCBI
13	Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M and Gustafsson JA: Human estrogen receptor beta-gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab. 82:4258–4265. 1997. View Article : Google Scholar : PubMed/NCBI
14	Kumar R, Zakharov MN, Khan SH, Miki R, Jang H, Toraldo G, Singh R, Bhasin S and Jasuja R: The dynamic structure of the estrogen receptor. J Amino Acids. 2011:8125402011. View Article : Google Scholar : PubMed/NCBI
15	Hewitt SC and Korach KS: Estrogen receptors: Structure, mechanisms and function. Rev Endocr Metab Disord. 3:193–200. 2022. View Article : Google Scholar : PubMed/NCBI
16	Barton M, Filardo EJ, Lolait SJ, Thomas P, Maggiolini M and Prossnitz ER: Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives. J Steroid Biochem Mol Biol. 176:4–15. 2018. View Article : Google Scholar : PubMed/NCBI
17	Saito K and Cui H: Estrogen receptor alpha splice variants, post-translational modifications and their physiological functions. Cells. 12:8952023. View Article : Google Scholar : PubMed/NCBI
18	Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V and Gannon F: Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 19:4688–4700. 2000. View Article : Google Scholar : PubMed/NCBI
19	Wang Z, Zhang X, Shen P, Loggie BW, Chang Y and Deuel TF: Identification, cloning and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005. View Article : Google Scholar : PubMed/NCBI
20	Warner M, Fan X, Strom A, Wu W and Gustafsson JÅ: 25 years of ERβ: A personal journey. J Mol Endocrinol. 68:R1–R9. 2021. View Article : Google Scholar : PubMed/NCBI
21	Monteiro FL, Stepanauskaite L, Archer A and Williams C: Estrogen receptor beta expression and role in cancers. J Steroid Biochem Mol Biol. 242:1065262024. View Article : Google Scholar : PubMed/NCBI
22	Jia M, Dahlman-Wright K and Gustafsson JÅ: Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab. 29:557–568. 2015. View Article : Google Scholar : PubMed/NCBI
23	Arao Y and Korach KS: The physiological role of estrogen receptor functional domains. Essays Biochem. 65:867–875. 2021. View Article : Google Scholar : PubMed/NCBI
24	Stender JD, Kim K, Charn TH, Komm B, Chang KC, Kraus WL, Benner C, Glass CK and Katzenellenbogen BS: Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol Cell Biol. 30:3943–3955. 2010. View Article : Google Scholar : PubMed/NCBI
25	Song RX, Zhang Z and Santen RJ: Estrogen rapid action via protein complex formation involving ERalpha and Src. Trends Endocrinol Metab. 16:347–353. 2005. View Article : Google Scholar : PubMed/NCBI
26	Kelly MJ and Levin ER: Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab. 12:152–156. 2001. View Article : Google Scholar : PubMed/NCBI
27	Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV and Auricchio F: PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:6050–6059. 2001. View Article : Google Scholar : PubMed/NCBI
28	Pedram A, Razandi M, Aitkenhead M, Hughes CC and Levin ER: Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem. 277:50768–50775. 2002. View Article : Google Scholar : PubMed/NCBI
29	Delmas PD: Treatment of postmenopausal osteoporosis. Lancet. 359:2018–2026. 2002. View Article : Google Scholar : PubMed/NCBI
30	Lindberg MK, Erlandsson M, Alatalo SL, Windahl S, Andersson G, Halleen JM, Carlsten H, Gustafsson JA and Ohlsson C: Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. J Endocrinol. 171:425–433. 2001. View Article : Google Scholar : PubMed/NCBI
31	Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, et al: Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 130:811–823. 2007. View Article : Google Scholar : PubMed/NCBI
32	Börjesson AE, Windahl SH, Karimian E, Eriksson EE, Lagerquist MK, Engdahl C, Antal MC, Krust A, Chambon P, Sävendahl L and Ohlsson C: The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice. Am J Physiol Endocrinol Metab. 302:E1381–E1389. 2012. View Article : Google Scholar : PubMed/NCBI
33	Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O'Brien CA and Manolagas SC: The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 24:323–334. 2010. View Article : Google Scholar : PubMed/NCBI
34	Manolagas SC, O'Brien CA and Almeida M: The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 9:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
35	Almeida M, Han L, Martin-Millan M, O'Brien CA and Manolagas SC: Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem. 282:27298–27305. 2007. View Article : Google Scholar : PubMed/NCBI
36	Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB and Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1056–1061. 1994. View Article : Google Scholar : PubMed/NCBI
37	Rochira V and Carani C: Aromatase deficiency in men: A clinical perspective. Nat Rev Endocrinol. 5:559–568. 2009. View Article : Google Scholar : PubMed/NCBI
38	Morishima A, Grumbach MM, Simpson ER, Fisher C and Qin K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80:3689–3698. 1995. View Article : Google Scholar : PubMed/NCBI
39	Conte FA, Grumbach MM, Ito Y, Fisher CR and Simpson ER: A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 78:1287–1292. 1994. View Article : Google Scholar : PubMed/NCBI
40	Chen GG, Zeng Q and Tse GM: Estrogen and its receptors in cancer. Med Res Rev. 28:954–974. 2008. View Article : Google Scholar : PubMed/NCBI
41	Chan KKL, Siu MKY, Jiang YX, Wang JJ, Wang Y, Leung THY, Liu SS, Cheung ANY and Ngan HYS: Differential expression of estrogen receptor subtypes and variants in ovarian cancer: Effects on cell invasion, proliferation and prognosis. BMC Cancer. 17:6062017. View Article : Google Scholar : PubMed/NCBI
42	Ciucci A, Zannoni GF, Travaglia D, Petrillo M, Scambia G and Gallo D: Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2 and ERβ5 in advanced serous ovarian cancer. Gynecol Oncol. 132:351–359. 2014. View Article : Google Scholar : PubMed/NCBI
43	Ignatov T, Modl S, Thulig M, Weißenborn C, Treeck O, Ortmann O, Zenclussen A, Costa SD, Kalinski T and Ignatov A: GPER-1 acts as a tumor suppressor in ovarian cancer. J Ovarian Res. 6:512013. View Article : Google Scholar : PubMed/NCBI
44	Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE and Prossnitz ER: GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol. 114:465–471. 2009. View Article : Google Scholar : PubMed/NCBI
45	Ramírez-de-Arellano A, Pereira-Suárez AL, Rico-Fuentes C, López-Pulido EI, Villegas-Pineda JC and Sierra-Diaz E: Distribution and effects of estrogen receptors in prostate cancer: Associated molecular mechanisms. Front Endocrinol (Lausanne). 12:8115782022. View Article : Google Scholar : PubMed/NCBI
46	Bonkhoff H: Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression. Prostate. 78:2–10. 2018. View Article : Google Scholar : PubMed/NCBI
47	Ryu WS, Kim JH, Jang YJ, Park SS, Um JW, Park SH, Kim SJ, Mok YJ and Kim CS: Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
48	Deng H, Huang X, Fan J, Wang L, Xia Q, Yang X, Wang Z and Liu L: A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis. Oncol Rep. 24:171–176. 2010.PubMed/NCBI
49	Xu CY, Guo JL, Jiang ZN, Xie SD, Shen JG, Shen JY and Wang LB: Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol. 17:2503–2509. 2010. View Article : Google Scholar : PubMed/NCBI
50	Jacenik D and Krajewska WM: Significance of G protein-coupled estrogen receptor in the pathophysiology of irritable bowel syndrome, inflammatory bowel diseases and colorectal cancer. Front Endocrinol (Lausanne). 11:3902020. View Article : Google Scholar : PubMed/NCBI
51	Baldissera VD, Alves AF, Almeida S, Porawski M and Giovenardi M: Hepatocellular carcinoma and estrogen receptors: Polymorphisms and isoforms relations and implications. Med Hypotheses. 86:67–70. 2016. View Article : Google Scholar : PubMed/NCBI
52	Wei T, Chen W, Wen L, Zhang J, Zhang Q, Yang J, Liu H, Chen BW, Zhou Y, Feng X, et al: G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis. Cancer Lett. 382:195–202. 2016. View Article : Google Scholar : PubMed/NCBI
53	Gupta VK, Banerjee S and Saluja AK: Learning from gender disparity: Role of estrogen receptor activation in coping with pancreatic cancer. Cell Mol Gastroenterol Hepatol. 10:862–863. 2020. View Article : Google Scholar : PubMed/NCBI
54	Dika E, Patrizi A, Lambertini M, Manuelpillai N, Fiorentino M, Altimari A, Ferracin M, Lauriola M, Fabbri E, Campione E, et al: Estrogen receptors and melanoma: A review. Cells. 8:14632019. View Article : Google Scholar : PubMed/NCBI
55	He M, Yu W, Chang C, Miyamoto H, Liu X, Jiang K and Yeh S: Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. Mol Oncol. 14:1779–1799. 2020. View Article : Google Scholar : PubMed/NCBI
56	Liu S, Hu C, Li M, An J, Zhou W, Guo J and Xiao Y: Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression. Cell Death Dis. 13:702022. View Article : Google Scholar : PubMed/NCBI
57	Liu C, Liao Y, Fan S, Tang H, Jiang Z, Zhou B, Xiong J, Zhou S, Zou M and Wang J: G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1. Med Oncol. 32:1042015. View Article : Google Scholar : PubMed/NCBI
58	Heer E, Harper A, Escandor N, Sung H, McCormack V and Fidler-Benaoudia MM: Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study. Lancet Glob Health. 8:e1027–e1037. 2020. View Article : Google Scholar : PubMed/NCBI
59	Cserni G: Histological type and typing of breast carcinomas and the WHO classification changes over time. Pathologica. 112:25–41. 2020. View Article : Google Scholar : PubMed/NCBI
60	Chen P, Li B and Ou-Yang L: Role of estrogen receptors in health and disease. Front Endocrinol (Lausanne). 13:8390052022. View Article : Google Scholar : PubMed/NCBI
61	Huang B, Omoto Y, Iwase H, Yamashita H, Toyama T, Coombes RC, Filipovic A, Warner M and Gustafsson JÅ: Differential expression of estrogen receptor α, β1 and β2 in lobular and ductal breast cancer. Proc Natl Acad Sci USA. 111:1933–1938. 2014. View Article : Google Scholar : PubMed/NCBI
62	Beral V; Million Women Study Collaborators, : Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362:419–427. 2003. View Article : Google Scholar : PubMed/NCBI
63	Salagame U, Canfell K and Banks E: An epidemiological overview of the relationship between hormone replacement therapy and breast cancer. Expert Rev Endocrinol Metab. 6:397–409. 2011. View Article : Google Scholar : PubMed/NCBI
64	Meng YG, Han WD, Zhao YL, Huang K, Si YL, Wu ZQ and Mu YM: Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin. Cell Res. 17:869–880. 2007. View Article : Google Scholar : PubMed/NCBI
65	Xu X, Zhang M, Xu F and Jiang S: Wnt signaling in breast cancer: Biological mechanisms, challenges and opportunities. Mol Cancer. 19:1652020. View Article : Google Scholar : PubMed/NCBI
66	Anbalagan M and Rowan BG: Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer. Mol Cell Endocrinol. 418:Pt 3:264–272. 2015. View Article : Google Scholar : PubMed/NCBI
67	Tsai EM, Wang SC, Lee JN and Hung MC: Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res. 61:8390–8392. 2001.PubMed/NCBI
68	Dustin D, Gu G and Fuqua SAW: ESR1 mutations in breast cancer. Cancer. 125:3714–3728. 2019. View Article : Google Scholar : PubMed/NCBI
69	Toy W, Weir H, Razavi P, Lawson M, Goeppert AU, Mazzola AM, Smith A, Wilson J, Morrow C, Wong WL, et al: Activating ESR1 mutations differentially affect the efficacy of ER antagonists. Cancer Discov. 7:277–287. 2017. View Article : Google Scholar : PubMed/NCBI
70	Klinge CM, Riggs KA, Wickramasinghe NS, Emberts CG, McConda DB, Barry PN and Magnusen JE: Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription. Mol Cell Endocrinol. 323:268–276. 2010. View Article : Google Scholar : PubMed/NCBI
71	Wang ZY and Yin L: Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer. Mol Cell Endocrinol. 418:Pt 3:193–206. 2015. View Article : Google Scholar : PubMed/NCBI
72	Giacinti L, Claudio PP, Lopez M and Giordano A: Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist. 11:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
73	Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA and Dahlman-Wright K: Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res. 67:3955–3962. 2007. View Article : Google Scholar : PubMed/NCBI
74	Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK and Fuqua SA: Low levels of estrogen receptor b protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res. 10:7490–7499. 2004. View Article : Google Scholar : PubMed/NCBI
75	Markey GC, Cullen R, Diggin P, Hill AD, Mc Dermott EW, O'Higgins NJ and Duffy MJ: Estrogen receptor-beta mRNA is associated with adverse outcome in patients with breast cancer. Tumour Biol. 30:171–175. 2009. View Article : Google Scholar : PubMed/NCBI
76	Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson JA and Rochefort H: Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin Cancer Res. 10:5769–5776. 2004. View Article : Google Scholar : PubMed/NCBI
77	Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT, et al: Nuclear and cytoplasmic expression of ERbeta1, ERbeta2 and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res. 14:5228–5235. 2008. View Article : Google Scholar : PubMed/NCBI
78	Lee MT, Ho SM, Tarapore P, Chung I and Leung YK: Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12. Neoplasia. 15:1262–1271. 2013. View Article : Google Scholar : PubMed/NCBI
79	Ignatov T, Weißenborn C, Poehlmann A, Lemke A, Semczuk A, Roessner A, Costa SD, Kalinski T and Ignatov A: GPER-1 expression decreases during breast cancer tumorigenesis. Cancer Invest. 31:309–315. 2013. View Article : Google Scholar : PubMed/NCBI
80	Fan X, Xu H, Warner M and Gustafsson JA: ERbeta in CNS: New roles in development and function. Prog Brain Res. 181:233–250. 2010. View Article : Google Scholar : PubMed/NCBI
81	Zuloaga DG, Puts DA, Jordan CL and Breedlove SM: The role of androgen receptors in the masculinization of brain and behavior: What we've learned from the testicular feminization mutation. Horm Behav. 53:613–626. 2008. View Article : Google Scholar : PubMed/NCBI
82	Biegon A: In vivo visualization of aromatase in animals and humans. Front Neuroendocrinol. 40:42–51. 2016. View Article : Google Scholar : PubMed/NCBI
83	Kudwa AE, Bodo C, Gustafsson JA and Rissman EF: A previously uncharacterized role for estrogen receptor beta: Defeminization of male brain and behavior. Proc Natl Acad Sci USA. 102:4608–4612. 2005. View Article : Google Scholar : PubMed/NCBI
84	Skordis N, Kyriakou A, Dror S, Mushailov A and Nicolaides NC: Gender dysphoria in children and adolescents: An overview. Hormones (Athens). 19:267–276. 2020. View Article : Google Scholar : PubMed/NCBI
85	Henningsson S, Westberg L, Nilsson S, Lundström B, Ekselius L, Bodlund O, Lindström E, Hellstrand M, Rosmond R, Eriksson E and Landén M: Sex steroid-related genes and male-to-female transsexualism. Psychoneuroendocrinology. 30:657–664. 2005. View Article : Google Scholar : PubMed/NCBI
86	Hare L, Bernard P, Sánchez FJ, Baird PN, Vilain E, Kennedy T and Harley VR: Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biol Psychiatry. 65:93–96. 2009. View Article : Google Scholar : PubMed/NCBI
87	Ujike H, Otani K, Nakatsuka M, Ishii K, Sasaki A, Oishi T, Sato T, Okahisa Y, Matsumoto Y, Namba Y, et al: Association study of gender identity disorder and sex hormone-related genes. Prog Neuropsychopharmacol Biol Psychiatry. 33:1241–1244. 2009. View Article : Google Scholar : PubMed/NCBI
88	Fernández R, Esteva I, Gómez-Gil E, Rumbo T, Almaraz MC, Roda E, Haro-Mora JJ, Guillamón A and Pásaro E: Association study of ERβ, AR and CYP19A1 genes and MtF transsexualism. J Sex Med. 11:2986–2994. 2014. View Article : Google Scholar : PubMed/NCBI
89	Cortés-Cortés J, Fernández R, Teijeiro N, Gómez-Gil E, Esteva I, Almaraz MC, Guillamón A and Pásaro E: Genotypes and Haplotypes of the Estrogen Receptor α Gene (ESR1) Are Associated With Female-to-Male Gender Dysphoria. J Sex Med. 14:464–472. 2017. View Article : Google Scholar : PubMed/NCBI
90	Fernández R, Guillamon A, Cortés-Cortés J, Gómez-Gil E, Jácome A, Esteva I, Almaraz M, Mora M, Aranda G and Pásaro E: Molecular basis of Gender Dysphoria: Androgen and estrogen receptor interaction. Psychoneuroendocrinology. 98:161–167. 2018. View Article : Google Scholar : PubMed/NCBI
91	Foreman M, Hare L, York K, Balakrishnan K, Sánchez FJ, Harte F, Erasmus J, Vilain E and Harley VR: Genetic link between gender dysphoria and sex hormone signaling. J Clin Endocrinol Metab. 104:390–396. 2019. View Article : Google Scholar : PubMed/NCBI
92	Ramírez KDV, Fernández R, Delgado-Zayas E, Gómez-Gil E, Esteva I, Guillamon A and Pásaro E: Implications of the Estrogen Receptor Coactivators SRC1 and SRC2 in the Biological Basis of Gender Incongruence. Sex Med. 9:1003682021. View Article : Google Scholar : PubMed/NCBI
93	Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M and Gustafsson JA: Mechanisms of estrogen action. Physiol Rev. 81:1535–1565. 2001. View Article : Google Scholar : PubMed/NCBI
94	McKenna NJ, Lanz RB and O'Malley BW: Nuclear receptor coregulators: Cellular and molecular biology. Endocr Rev. 20:321–344. 1999. View Article : Google Scholar : PubMed/NCBI
95	Yi P, Wang Z, Feng Q, Pintilie GD, Foulds CE, Lanz RB, Ludtke SJ, Schmid MF, Chiu W and O'Malley BW: Structure of a biologically active estrogen receptor-coactivator complex on DNA. Mol Cell. 57:1047–1058. 2015. View Article : Google Scholar : PubMed/NCBI
96	Maioli S, Leander K, Nilsson P and Nalvarte I: Estrogen receptors and the aging brain. Essays Biochem. 65:913–925. 2021. View Article : Google Scholar : PubMed/NCBI
97	Osterlund MK and Hurd YL: Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol. 64:251–267. 2001. View Article : Google Scholar : PubMed/NCBI
98	Mehra RD, Sharma K, Nyakas C and Vij U: Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: A qualitative and quantitative study. Brain Res. 1056:22–35. 2005. View Article : Google Scholar : PubMed/NCBI
99	González M, Cabrera-Socorro A, Pérez-García CG, Fraser JD, López FJ, Alonso R and Meyer G: Distribution patterns of estrogen receptor alpha and beta in the human cortex and hippocampus during development and adulthood. J Comp Neurol. 503:790–802. 2007. View Article : Google Scholar : PubMed/NCBI
100	Toffoletto S, Lanzenberger R, Gingnell M, Sundström-Poromaa I and Comasco E: Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review. Psychoneuroendocrinology. 50:28–52. 2014. View Article : Google Scholar : PubMed/NCBI
101	Waters EM, Yildirim M, Janssen WG, Lou WY, McEwen BS, Morrison JH and Milner TA: Estrogen and aging affect the synaptic distribution of estrogen receptor β-immunoreactivity in the CA1 region of female rat hippocampus. Brain Res. 1379:86–97. 2011. View Article : Google Scholar : PubMed/NCBI
102	Morrison JH, Brinton RD, Schmidt PJ and Gore AC: Estrogen, menopause and the aging brain: How basic neuroscience can inform hormone therapy in women. J Neurosci. 26:10332–10348. 2006. View Article : Google Scholar : PubMed/NCBI
103	Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI, Carpenter LL, Nemeroff CB, McDonald WM and Kalin NH; APA Council of Research Task Force on Novel Biomarkers and Treatments, : Hormonal treatments for major depressive disorder: State of the Art. Am J Psychiatry. 177:686–705. 2020. View Article : Google Scholar : PubMed/NCBI
104	Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S and Kotchen JM: Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: The Women's Health Initiative Memory Study. J Am Geriatr Soc. 59:57–66. 2011. View Article : Google Scholar : PubMed/NCBI
105	Kilpi F, Soares ALG, Fraser A, Nelson SM, Sattar N, Fallon SJ, Tilling K and Lawlor DA: Changes in six domains of cognitive function with reproductive and chronological ageing and sex hormones: A longitudinal study in 2411 UK mid-life women. BMC Womens Health. 20:1772020. View Article : Google Scholar : PubMed/NCBI
106	Wood Alexander M, Wu CY, Coughlan GT, Puri T, Buckley RF, Palta P, Swardfager W, Masellis M, Galea LAM, Einstein G, et al: Associations between age at menopause, vascular risk and 3-year cognitive change in the canadian longitudinal study on aging. Neurology. 102:e2092982024. View Article : Google Scholar : PubMed/NCBI
107	Georgakis MK, Kalogirou EI, Diamantaras AA, Daskalopoulou SS, Munro CA, Lyketsos CG, Skalkidou A and Petridou ET: Age at menopause and duration of reproductive period in association with dementia and cognitive function: A systematic review and meta-analysis. Psychoneuroendocrinology. 73:224–243. 2016. View Article : Google Scholar : PubMed/NCBI
108	Song YJ, Li SR, Li XW, Chen X, Wei ZX, Liu QS and Cheng Y: The effect of estrogen replacement therapy on Alzheimer's disease and parkinson's disease in postmenopausal women: A meta-analysis. Front Neurosci. 14:1572020. View Article : Google Scholar : PubMed/NCBI